Multi-omics decodes a defect-interface dual-engineered PtPb@SbO3-x nanozyme for NIR-II photothermal-amplified eradication of drug-resistant pneumonia
This study establishes a non-antibiotic nanozyme-based therapeutic strategy that is efficient, low in toxicity, and non-invasive for treating MDR bacterial infections and provides a solid theoretical basis and technical framework for the rational design of defect/interface dual-engineered nanoplatforms.